CommercialPrior AuthMedium impact
06.02.31g, Genetic Testing for Congenital Long QT Syndrome (Independence Administrators)
Independence Blue Cross·Cardiology, Genetics·Medical Policy
Effective date
Mar 5, 2025
We identified it
Jun 19, 2026
Summary
Independence Administrators has reissued policy 06.02.31g on genetic testing for congenital Long QT Syndrome, effective March 5, 2025. The billing team must review the full policy text to identify specific coverage criteria, prior authorization requirements, and applicable billing codes for genetic testing related to Long QT Syndrome diagnosis and management.
Action Required
By March 5, 2025: Billing team must obtain and review the complete policy text from the provided URL to identify: (1) specific CPT/HCPCS codes for Long QT Syndrome genetic testing that require prior authorization, (2) medical necessity criteria, and (3) any documentation requirements. Update billing software and clinical encounter forms to reflect prior authorization workflows and documentation requirements before the effective date. Contact Independence Administrators directly if the full policy document is not accessible via the URL to prevent claim denials. Failure to implement required prior authorization will result in claim rejections.